Product Information

GLIMEPIRIDE 2 MG TABLET is a generic product labeled by Micro Labs Limited, priced at $0.0373 per EA under NDC 42571010101. Its NADAC has been published 484 times since Nov 28, 2013.

FDA first approved this application on Jun 29, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Glimepiride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

GLIMEPIRIDE 2 MG TABLET

Glimepiride
$0.0373per EA
High Outlier

Strength

2 mg/1

Manufacturer

Micro Labs Limited

NDC

42571010101

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

GLIMEPIRIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA091220

FDA Approved

6/29/2012

TE Code

AB

On Market Since

6/13/2013

Pharmacological Classes

Sulfonylurea Compounds
Sulfonylurea

Price Statistics

The NADAC for GLIMEPIRIDE 2 MG TABLET has been published 484 times since Nov 28, 2013, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.0373 per EA
All-time high$0.1433 (Jan 13, 2016)
All-time low$0.0284 (Apr 17, 2024)
52-week high$0.0374
52-week low$0.0295
Median price$0.0390
Average price$0.0538
Largest weekly change+85.6% (Feb 18, 2015)
Weeks tracked484
Tracking sinceNov 28, 2013

Price History

1W

-0.3%

1M

-0.3%

3M

+4.0%

6M

+26.4%

1Y

+0.3%

3Y

+3.9%

5Y

-26.3%

All

-0.1%

Generic Alternatives

The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of GLIMEPIRIDE 2 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for GLIMEPIRIDE 2 MG TABLET, manufactured by Micro Labs Limited, is $0.0373 per EA (NDC 42571010101), effective Aug 19, 2026.

How has the price of GLIMEPIRIDE 2 MG TABLET changed over time?

Over the history we have for it, the NADAC for GLIMEPIRIDE 2 MG TABLET has held within roughly two percent of its current level. It has been tracked across 484 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for GLIMEPIRIDE 2 MG TABLET?

Since Nov 28, 2013, the NADAC for GLIMEPIRIDE 2 MG TABLET has ranged from a low of $0.0284 (Apr 17, 2024) to a high of $0.1433 (Jan 13, 2016), with a median of $0.0390 per EA.

Are there cheaper alternatives to GLIMEPIRIDE 2 MG TABLET?

Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GLIMEPIRIDE 2 MG TABLET, is $0.0358 per EA — about 4% below GLIMEPIRIDE 2 MG TABLET.

Who manufactures GLIMEPIRIDE 2 MG TABLET?

GLIMEPIRIDE 2 MG TABLET (NDC 42571010101) is labeled by Micro Labs Limited, and CMS classifies it as a generic product.